Purchase Order 12805B22P0237
Award Date 8/25/22
Potential Completion Date 11/11/22
Potential Value $88K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Piscataway, NJ 08854, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract was awarded by the Plains Area division of a civilian federal agency to Genscript USA Inc., a biotechnology company based in New Jersey. The $3,458.11 firm fixed-price purchase order is for protein expression and purification services. The contract does not have a set-aside designation. Genscript has received numerous prime and subcontract awards from federal agencies like the Department of Health and Human Services (including the National Institutes of Health, Centers...
- This federal contract award to Genscript USA Inc., a biotechnology company based in New Jersey, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The $4,196.16 firm fixed-price purchase order is for gene synthesis services. Genscript, a for-profit organization, has a history of providing a wide range of molecular biology products and services to...
- This federal contract award was made by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $10,470.54 firm fixed price purchase order was awarded on November 1, 2019 with a completion date of October 29, 2020. Genscript provides a wide range of products and services to federal agencies in the areas of biomedical research...
- The U.S. Department of Agriculture's Midwest Area awarded a $3,371.61 firm fixed-price purchase order to Genscript USA Inc. for protein sequencing services on May 18, 2015, with completion targeted for May 31, 2016. The contract, issued without a set-aside designation, leverages Genscript's specialized capabilities in molecular biology and protein production to support federal research initiatives. Performance will be executed at the contractor's facility in Piscataway, New Jersey. Genscript USA...
- Genscript USA Inc., a biotechnology company based in New Jersey, was awarded a $6,463.55 firm fixed-price purchase order contract by the USDA's Northeast Area to generate an IFNAR1 knockout HEK293 cell line. This contract is not set aside for any specific business category. Genscript has a significant blanket purchase agreement (BPA) worth up to $1.5 million with USDA's Animal and Plant Health Inspection Service (APHIS) to provide SARS-CoV-2 surrogate virus neutralization test kits and...
- The U.S. Department of Agriculture awarded a $22,817.95 firm fixed-price purchase order to Genscript USA Inc. on September 15, 2017, for Calonectria antibody production based on GenScript Quote #1410287 dated October 10, 2017. The contract, with an ultimate completion date of September 30, 2019, was issued without a set-aside designation. Work will be performed at the contractor's facility in Piscataway, New Jersey. This award supports APHIS' (Animal and Plant Health Inspection Service) research...
- The U.S. government awarded a $12,411.55 firm fixed-price purchase order to Genscript USA Inc. on September 15, 2021, for animal immunization, cell fusion, subcloning, antibody production, purification, and sequencing services. The contract, which was completed on March 16, 2022, was funded through a civilian federal agency within the Southeast Area and performed at Genscript's facility in Piscataway, New Jersey. No set-aside designation was applied to this award. Genscript USA Inc., a...
- This federal contract award to Genscript USA Inc., a biotechnology company, was issued by the National Cancer Institute, which is part of the Department of Health and Human Services' National Institutes of Health. The $17,250.82 firm fixed price purchase order is for the provision of biological products and services, with a completion date of June 26, 2024. Genscript has previously received other prime federal contracts to supply customized DNA, antibodies, proteins, and other materials for...
- This $4,448.22 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for custom protein and DNA synthesis services to support biomedical research and public health initiatives. Genscript specializes in providing a range of molecular biology products and services, including gene...
- This firm fixed-price purchase order, valued at $14,607.70, was awarded by the National Institute of Child Health and Human Development (NICHD) to Genscript USA Inc. for gene synthesis and cloning services. The ultimate completion date is August 29, 2024. Genscript is a biotechnology company based in Piscataway, New Jersey that specializes in molecular biology products and services to support biomedical research and public health initiatives for various federal agencies, including the National...